# Duration of Clopidogrel Therapy After Drug-Eluting Stent (DES-LATE)

> **NCT01186146** · PHASE4 · COMPLETED · sponsor: **Seung-Jung Park** · enrollment: 5000 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Aspirin monotherapy
- **DRUG:** Aspirin,Clopidogrel

## Key facts

- **NCT ID:** NCT01186146
- **Lead sponsor:** Seung-Jung Park
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2012-12
- **Final completion:** 2013-10
- **Target enrollment:** 5000 (ACTUAL)
- **Last updated:** 2014-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01186146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01186146, "Duration of Clopidogrel Therapy After Drug-Eluting Stent (DES-LATE)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01186146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*